Currently this content is only available in German.
Dieser Inhalt ist momentan nur auf Deutsch verfügbar.

0900 712 712
(3.23 CHF / min. from the Swiss landline, possibly additionally 8 Rp. / min. in the waiting loop by network operator)
0900 712 713

(3.12 CHF / min. for calls from prepaid cell phones, possibly additionally 8 Rp. / min. in the waiting loop by network operator)

Notfallnummern

Anmeldung

Sie haben bereits ein Konto?

 

Sie sind noch nicht registriert?

Emergency Contact 24h

0900 712 712

(3.23 CHF / min. from the Swiss landline, possibly additionally 8 Rp. / min. by network operator)

 
 

0900 712 713

(3.12 CHF / min. for calls from prepaid cell phones, possibly additionally 8 Rp. / min. by network operator)


Important Numbers

  • 144   Ambulance
  • 145   Tox Center (Poisoning)
  • 117   Police
  • 118   Fire Department

Kontakt Box

UKBB

University Children’s Hospital Basel
Spitalstrasse 33
4056 Basel
Switzerland

T +41 61 704 12 12

Contact

Appointment cancellation
Collection / Reminder 
Patient invoice
Please contact me
Other
empty
Appointment cancellation

For making an appointment or the postponement of an appointment, please contact polyclinic head office +41 61 704 12 20

 
Collection / Reminder 

Collection / Reminder

 
Patient invoice

Patient invoice

 
Please contact me

Please contact me

 
 

How would you like to be contacted?

 
Other

Other

 
empty
 
 
 

Molecular Therapeutic Strategies in Pediatric Surgery

The molecular research of our group is driven by clinical questions. Our intention is to generate knowledge that can potentially be translated back to the clinic to have an impact on future treatment.

The main focus of our research is surgical oncology. Pediatric tumor disease is still life threatening and can already occur in neonates. Surgical, oncological and interdisciplinary approaches have improved the outcome in the past. Nevertheless, there is a need for identifying underlying mechanisms of tumor development and tumor cell migration that can lead to the development of novel therapeutic approaches. The research interest of our group is focused on investigating the metastatic process and on understanding which cellular and genetic changes are involved in this process.

Neuroblastoma is a rare disease, but still it is the most common extracranial solid tumor in childhood. Rareness presents great challenges to introduce new therapeutic drugs. While investigating hypoxia-dependent modes of tumor cell migration, we are working with newly established preclinical models to mimic neuroblastoma and use rapid drug response assessment to evaluate novel therapeutics, including modern immunotherapeutic approaches amongst others.

Further research areas of our group include other fields of molecular pediatric surgical research such as congenital malformations, various aspects of neonatal and visceral diseases e.g. membrane water transport in appendicitis, influence of membrane water transport and hypoxia in the enteric nervous system, and development of congenital diseases.  

We have active collaborations with the Department Biomedicine Basel, the Department of Biomedical Engineering Basel, the University of Basel, the ETH Zürich, the University of Florence and the University Medical center Hamburg-Eppendorf amongst others. 

Only available in German

 

Group members

  • Stefanie Volkart, MD
  • Zihe Huo, PhD student
  • Urs Kym, MSc
  • Nicola Pini, MD student
  • Antonia Leutert, MD student
  • Remo Bilang, MD student
 
Print
You can also find us here
UKBB FacebookUKBB YoutubeUKBB TwitterUKBB Instagram

Emergencies

0900 712 712

(3.23 CHF/min. CH-landline, possibly additionally 8 Rp. / min. by network operator)

0900 712 713

(3.12 CHF/min. prepaid cell phones, possibly additionally 8 Rp. / min. by network operator)

Site Map

Contact

University Children’s Hospital Basel
Spitalstrasse 33
4056 Basel / Switzerland

T +41 61 704 12 12
Contact

 

Emergency

Contact

University Children’s Hospital Basel
Spitalstrasse 33
4056 Basel / Switzerland

T +41 61 704 12 12
Contact

© UKBB, 2020